澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ADALTA LTD

0.003

-0.001-25.00%

成交量：19.85萬

成交額：794

市值：963.65萬

市盈率：-1.30

高：0.004

開：0.004

低：0.003

收：0.004

52周最高：0.050

52周最低：0.003

股本：32.12億

流通股本：24.61億

量比：0.65

換手率：0.01%

股息：- -

股息率：- -

每股收益(TTM):-0.002

每股收益(LYR):-0.002

淨資產收益率：-628.72%

總資產收益率：-139.87%

市淨率：26.03

市盈率(LYR):-1.30

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Adalta攜手Oribiotech與Cell Therapies簽署諒解備忘錄將Iro平台引入澳大利亞及亞太市場

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/1AD.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"1AD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AD.AU\",,,,,undefined,":{"symbol":"1AD.AU","market":"AU","secType":"STK","nameCN":"ADALTA LTD","latestPrice":0.003,"timestamp":1787638320000,"preClose":0.004,"halted":0,"volume":198514,"delay":0,"changeRate":-0.25,"nameEN":"ADALTA LTD","floatShares":2461369466,"shares":3212169000,"eps":-0.0023,"marketStatus":"未開盤","change":-0.001,"latestTime":"08-25 16:12:00 AEST","open":0.004,"high":0.004,"low":0.003,"amount":794,"amplitude":0.25,"askPrice":0.004,"askSize":9881489,"bidPrice":0.003,"bidSize":65680194,"shortable":3,"etf":0,"ttmEps":-0.0023,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.004,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.6520221116942627,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"1AD.AU","preClose":0.004,"auctionPrice":0.004,"auctionVolume":198000,"auction":3,"marketStatus":"盘后竞价","timestamp":1787637892817}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AD.AU\",,,,,undefined,":{"symbol":"1AD.AU","floatShares":2461369466,"roa":"-139.87%","roe":"-628.72%","lyrEps":-0.0023,"volumeRatio":0.6520221116942627,"shares":3212169000,"dividePrice":0,"high":0.004,"amplitude":0.25,"preClose":0.004,"low":0.003,"week52Low":0.003,"pbRate":"26.03","psRate":"20.15","week52High":0.05,"institutionHeld":0,"latestPrice":0.003,"committee":0.738452,"eps":-0.0023,"divideRate":0,"volume":198514,"delay":0,"ttmEps":-0.0023,"open":0.004,"prevYearClose":0.003,"prevWeekClose":0.003,"prevMonthClose":0.003,"prevQuarterClose":0.003,"fiveDayClose":0.003,"twentyDayClose":0.004,"sixtyDayClose":0.004,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/1AD.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-12-09","symbol":"1AD.AU","defaultRemindTime":1765234800000,"type":"split","dateTimestamp":1765198800000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"AU","date":"2021-12-17","symbol":"1AD.AU","defaultRemindTime":1639695600000,"type":"split","dateTimestamp":1639659600000,"forFactor":990277,"toFactor":1000000,"ratio":0.990277},{"market":"AU","date":"2020-08-13","symbol":"1AD.AU","defaultRemindTime":1597276800000,"type":"split","dateTimestamp":1597240800000,"forFactor":981818,"toFactor":1000000,"ratio":0.981818}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"1AD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"1AD.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1128114587","title":"Adalta攜手Oribiotech與Cell Therapies簽署諒解備忘錄 將Iro平台引入澳大利亞及亞太市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1128114587","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128114587?lang=zh_tw&edition=fundamental","pubTime":"2026-04-21 07:20","pubTimestamp":1776727255,"startTime":"0","endTime":"0","summary":"澳大利亚生物技术公司Adalta Ltd与合作伙伴Oribiotech、Cell Therapies共同签署了一份具有战略意义的谅解备忘录。该协议旨在将创新的Iro技术平台推广至澳大利亚及亚太地区。\n这一合作标志着三方在细胞治疗领域的深度协同。通过资源整合与技术共享，合作伙伴计划加速Iro平台在亚太市场的商业化进程，为当地医疗健康产业注入新的技术活力。\n此次布局不仅展现了Adalta Ltd在全球生物技术领域的战略眼光，也预示着亚太地区将成为细胞治疗技术发展的重要增长极。合作各方将共同探索该技术在不同医疗场景中的应用潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["1AD.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/1AD.AU\",params:#limit:6,delay:true,,,undefined,":[]}}